( June 16, 2025, 4:10 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on June 16 denied a drug manufacturer’s petition for certiorari in the long-running Fosamax femur fracture multidistrict litigation, letting stand a Third Circuit U.S. Court of Appeals decision that found that state law claims are not preempted and reversed a decision that awarded the drug manufacturer summary judgment in 1,046 cases....